Diabetes drug results do little for J&J’s shares By: MarketWatch October 02, 2012 at 13:19 PM EDT Positive results from a drug study don’t do much to lift the fortunes of drug giant Johnson & Johnson. Read More >> Related Stocks: DaVita HealthCare Partner Illumina Inc Johnson & Johnson Roche Holding AG Basel American Depositary Shares